Kelly Tyler

911 total citations
23 papers, 318 citations indexed

About

Kelly Tyler is a scholar working on Pathology and Forensic Medicine, Dermatology and Epidemiology. According to data from OpenAlex, Kelly Tyler has authored 23 papers receiving a total of 318 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Pathology and Forensic Medicine, 9 papers in Dermatology and 6 papers in Epidemiology. Recurrent topics in Kelly Tyler's work include Autoimmune Bullous Skin Diseases (8 papers), Cutaneous lymphoproliferative disorders research (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). Kelly Tyler is often cited by papers focused on Autoimmune Bullous Skin Diseases (8 papers), Cutaneous lymphoproliferative disorders research (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). Kelly Tyler collaborates with scholars based in United States, Australia and China. Kelly Tyler's co-authors include Matthew Zirwas, Benjamin H. Kaffenberger, Hugh A. Tilson, G. Jean Harry, Jessica Kaffenberger, Christian Lefebvre d’Hellencourt, Henry K. Wong, Pierluigi Porcu, Alejandro A. Gru and Shawn G. Kwatra and has published in prestigious journals such as Journal of Investigative Dermatology, Journal of the American Academy of Dermatology and Toxicology and Applied Pharmacology.

In The Last Decade

Kelly Tyler

23 papers receiving 302 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kelly Tyler United States 13 128 63 56 47 37 23 318
Ayman Abdelmaksoud Egypt 13 190 1.5× 40 0.6× 34 0.6× 69 1.5× 24 0.6× 38 366
Candrice Heath United States 13 249 1.9× 35 0.6× 35 0.6× 65 1.4× 33 0.9× 58 440
Nives Pustišek Croatia 11 268 2.1× 41 0.7× 61 1.1× 57 1.2× 14 0.4× 42 426
Ágnes Kinyó Hungary 11 131 1.0× 57 0.9× 52 0.9× 55 1.2× 12 0.3× 31 320
Desirée Wiegleb Edström Sweden 13 370 2.9× 37 0.6× 57 1.0× 57 1.2× 41 1.1× 23 539
Hakan Turan Türkiye 12 99 0.8× 36 0.6× 64 1.1× 72 1.5× 27 0.7× 58 388
Zeynep Meltem Akkurt Türkiye 9 78 0.6× 34 0.5× 16 0.3× 47 1.0× 31 0.8× 32 220
Sarah Felton United Kingdom 12 194 1.5× 149 2.4× 20 0.4× 76 1.6× 32 0.9× 25 463
Melissa Danesh United States 11 203 1.6× 30 0.5× 40 0.7× 56 1.2× 47 1.3× 34 397
Ömer Kutlu Türkiye 12 226 1.8× 26 0.4× 47 0.8× 53 1.1× 24 0.6× 51 431

Countries citing papers authored by Kelly Tyler

Since Specialization
Citations

This map shows the geographic impact of Kelly Tyler's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kelly Tyler with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kelly Tyler more than expected).

Fields of papers citing papers by Kelly Tyler

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kelly Tyler. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kelly Tyler. The network helps show where Kelly Tyler may publish in the future.

Co-authorship network of co-authors of Kelly Tyler

This figure shows the co-authorship network connecting the top 25 collaborators of Kelly Tyler. A scholar is included among the top collaborators of Kelly Tyler based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kelly Tyler. Kelly Tyler is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tyler, Kelly, et al.. (2023). Xylazine-induced acute skin necrosis in two patients who inject fentanyl. JAAD Case Reports. 36. 113–115. 20 indexed citations
2.
Korman, Abraham M., Kelly Tyler, Jessica Kaffenberger, et al.. (2021). In vitro diagnostics for the medical dermatologist. Part II: Hypercoagulability tests. Journal of the American Academy of Dermatology. 85(2). 301–310. 2 indexed citations
3.
Korman, Abraham M., et al.. (2021). In vitro diagnostics for the medical dermatologist. Part I: Autoimmune tests. Journal of the American Academy of Dermatology. 85(2). 287–298. 2 indexed citations
4.
Tyler, Kelly, et al.. (2021). 304 Lifestyle modifications associated with symptom improvement in Hidradenitis Suppurativa patients. Journal of Investigative Dermatology. 141(5). S54–S54. 1 indexed citations
5.
Tyler, Kelly, et al.. (2021). Lifestyle modifications associated with symptom improvement in hidradenitis suppurativa patients. Archives of Dermatological Research. 314(3). 293–300. 25 indexed citations
6.
Marathe, Kalyani, et al.. (2021). NASPAG Clinical Opinion: Diagnosis and Management of Lichen Sclerosis in Pediatric and Adolescent Patients. Journal of Pediatric and Adolescent Gynecology. 35(2). 112–120. 7 indexed citations
7.
Smith, Zachary J., Kelly Tyler, Shufang Chang, et al.. (2021). Applying limiting entropy to quantify the alignment of collagen fibers by polarized light imaging. Mathematical Biosciences & Engineering. 18(3). 2331–2356. 2 indexed citations
8.
Tyler, Kelly. (2020). Cutaneous Disorders of Pregnancy. 2 indexed citations
9.
Dunaway, Spencer, Kelly Tyler, & Jessica Kaffenberger. (2019). Update on treatments for erosive vulvovaginal lichen planus. International Journal of Dermatology. 59(3). 297–302. 12 indexed citations
10.
Kaffenberger, Benjamin H., et al.. (2015). Extranodal Marginal Zone Lymphoma–like Presentations of Angioimmunoblastic T-Cell Lymphoma. American Journal of Dermatopathology. 37(8). 604–613. 19 indexed citations
11.
Tyler, Kelly, Bradley M. Haverkos, Eileen Hu, et al.. (2015). The Role of an Integrated Multidisciplinary Clinic in the Management of Patients with Cutaneous Lymphoma. Frontiers in Oncology. 5. 136–136. 24 indexed citations
12.
Tyler, Kelly, Alejandro A. Gru, Xiaoli Zhang, et al.. (2015). Primary Cutaneous B-Cell Lymphoma: Management and Patterns of Recurrence at the Multimodality Cutaneous Lymphoma Clinic of The Ohio State University. The Oncologist. 20(10). 1161–1166. 18 indexed citations
13.
Tyler, Kelly. (2014). Physiological Skin Changes During Pregnancy. Clinical Obstetrics & Gynecology. 58(1). 119–124. 34 indexed citations
14.
Tyler, Kelly & Matthew Zirwas. (2014). Is decreased ultraviolet exposure during childhood the cause of the increased prevalence of atopic dermatitis?. PubMed. 7(11). 38–9. 1 indexed citations
15.
Kaffenberger, Benjamin H., Kelly Tyler, Derek V. Chan, et al.. (2014). Current and potential immune therapies and vaccines in the management of psoriasis. Human Vaccines & Immunotherapeutics. 10(4). 876–886. 5 indexed citations
16.
Tyler, Kelly. (2014). Dermatologic Therapy in Pregnancy. Clinical Obstetrics & Gynecology. 58(1). 112–118. 13 indexed citations
17.
Tyler, Kelly & Matthew Zirwas. (2013). Contraception and the dermatologist. Journal of the American Academy of Dermatology. 68(6). 1022–1029. 21 indexed citations
18.
Tyler, Kelly & Matthew Zirwas. (2012). Pregnancy and dermatologic therapy. Journal of the American Academy of Dermatology. 68(4). 663–671. 26 indexed citations
19.
Tyler, Kelly, et al.. (2010). Civil commitment outcomes of incompetent defendants.. PubMed. 38(3). 349–58. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026